ATX-101 Double Chin Drug by KYTHERA FDA Approval Update 2015

KYTHERA Biopharmaceuticals, Inc. has announced on March 9, 2015 that the U.S. Food and Drug Administration’s (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has voted unanimously to support the approval of ATX-101 (deoxycholic acid) injection for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. This medical […]

ATX-101 Kythera’s Double Chin Fat Burner Drug

Kythera Biopharmaceuticals seems to have a breakthrough product in the form of ATX-101. ATX-101 is a drug currently on the final stages of testing and is intended for use for the reduction of submental fat, or more popularly known as ” Double Chin”. What is ATX-101? ATX-101 is a purified synthetic version of Deoxycholic Acid. Deoxycholic […]